Viveve Medical, Inc.
VIVE
$0.0002
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | 14.19% | 1.48% | 6.98% | -8.02% | -44.64% |
| Total Depreciation and Amortization | -6.38% | -7.84% | -15.00% | -2.44% | -24.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.85% | 24.54% | -6.96% | 1.06% | 964.05% |
| Change in Net Operating Assets | 178.22% | 22.07% | -142.49% | -6.27% | 1,037.76% |
| Cash from Operations | 26.66% | 10.20% | -57.64% | -21.18% | 28.70% |
| Capital Expenditure | -227.12% | -20.41% | 83.33% | -250.00% | -1,300.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -227.12% | -20.41% | 83.33% | -250.00% | -1,300.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 46.15% | -31.58% | 11.76% | -19.05% | -97.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 46.15% | -31.58% | 5.56% | -14.29% | -96.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.62% | 9.83% | -46.07% | -28.50% | 10.77% |